Vertex Pharmaceuticals (MEX:VRTX) Change In Inventory : MXN-9,963 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Vertex Pharmaceuticals Change In Inventory?

Vertex Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2024 was MXN-3,076 Mil. It means Vertex Pharmaceuticals's inventory increased by MXN3,076 Mil from Sep. 2024 to Dec. 2024 .

Vertex Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2024 was MXN-10,789 Mil. It means Vertex Pharmaceuticals's inventory increased by MXN10,789 Mil from Dec. 2023 to Dec. 2024 .

Vertex Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2024 was MXN25,139 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Vertex Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2024 was 239.75.

Inventory Turnover measures how fast the company turns over its inventory within a year. Vertex Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.38.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Vertex Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.38.

Vertex Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Vertex Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vertex Pharmaceuticals Change In Inventory Chart

Vertex Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-2,625.74

-1,903.70

-2,659.25

-5,480.99

-10,788.65

Vertex Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-1,188.20	-1,329.36	-1,963.92	-3,593.48	-3,076.22

Vertex Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-9,963 Mil.

Vertex Pharmaceuticals (MEX:VRTX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Vertex Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	23200.5235	/	8830.303	*	365 / 4
	=	239.75

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Vertex Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	8830.303	/	23200.5235
	=	0.38

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Vertex Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	23200.5235	/	60731.798
	=	0.38

Vertex Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Vertex Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Vertex Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vertex Pharmaceuticals Inc (MEX:VRTX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

VRTX:USA 1VRTX:Italy 0QZU:UK VX1:Germany VX1:Germany VX1:Germany VRTX34:Brazil VRTX:Austria

Address

50 Northern Avenue, Boston, MA, USA, 02210

Website

https://www.vrtx.com

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.